EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD.

Int J Mol Sci 2013 Dec 12;14(12):24154-68. Epub 2013 Dec 12.

Department of Oncohematology, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy.

Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent, chronic liver diseases, worldwide. It is a multifactorial disease caused by complex interactions between genetic, epigenetic and environmental factors. Recently, several microRNAs, some of which epigenetically regulated, have been found to be up- and/or down-regulated during NAFLD development. However, in NAFLD, the essential role of the Polycomb Group protein Enhancer of Zeste Homolog 2 (EZH2), which controls the epigenetic silencing of specific genes and/or microRNAs by trimethylating Lys27 on histone H3, still remains unknown. In this study, we demonstrate that the nuclear expression/activity of the EZH2 protein is down-regulated both in livers from NAFLD rats and in the free fatty acid-treated HepG2. The drop in EZH2 is inversely correlated with: (i) lipid accumulation; (ii) the expression of pro-inflammatory markers including TNF-α and TGF-β; and (iii) the expression of miR-200b and miR-155. Consistently, the pharmacological inhibition of EZH2 by 3-Deazaneplanocin A (DZNep) significantly reduces EZH2 expression/activity, while it increases lipid accumulation, inflammatory molecules and microRNAs. In conclusion, the results of this study suggest that the defective activity of EZH2 can enhance the NAFLD development by favouring steatosis and the de-repression of the inflammatory genes and that of specific microRNAs.

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms141224154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876102PMC
December 2013
12 Reads

Publication Analysis

Top Keywords

lipid accumulation
12
nafld development
8
ezh2
7
nafld
6
micrornas trimethylating
4
and/or micrornas
4
genes and/or
4
silencing specific
4
specific genes
4
ezh2 expression/activity
4
lys27 histone
4
remains unknown
4
unknown study
4
dznep reduces
4
histone remains
4
epigenetic silencing
4
reduces ezh2
4
trimethylating lys27
4
ezh2 controls
4
iii expression
4

Altmetric Statistics

References

(Supplied by CrossRef)
NAFLD in Asia—As common and important as in the West
Farrell et al.
Nat. Rev. Gastroenterol 2013
Nonalcoholic fatty liver disease
Law et al.
Clin. Liver Dis 2010
A myriad of pathways to NASH
Larrain et al.
Clin. Liver Dis 2012
Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases
Zimmer et al.
Best Pract. Res. Clin. Gastroenterol 2011
DNA methylation and hepatic insulin resistance and steatosis
Sookoian et al.
Curr. Opin. Clin. Nutr. Metab 2012
MicroRNAs and epigenetics
Sato et al.
FEBS J 2011
DNA methylation dynamics in health and disease
Bergman et al.
Nat. Struct. Mol. Biol 2013

Similar Publications